Literature DB >> 18248645

Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.

Yasuro Kumeda1, Masaaki Inaba, Shigeichi Shoji, Eiji Ishimura, Hiromi Inariba, Sachiko Yabe, Mikio Okamura, Yoshiki Nishizawa.   

Abstract

OBJECTIVE: We recently reported that glycated albumin (GA) is a better indicator of glycaemic control compared with glycated haemoglobin (HbA1c) in haemodialysis (HD) patients with type 2 diabetes. As poor glycaemic control is considered an independent risk factor for atherosclerosis in diabetes, the relationship between GA, HbA1c and arterial stiffening was examined in HD patients with type 2 diabetes. PATIENTS AND METHODS: The present study comprised 134 HD patients with type 2 diabetes, and 158 patients without diabetes. Brachial-ankle pulse wave velocity (baPWV) was measured in all patients using a waveform analyser.
RESULTS: The mean plasma glucose (PG), GA and HbA1c levels were 7.49 +/- 2.28 mmol/l, 20.8 +/- 5.57% and 5.62 +/- 1.26%, respectively, in HD patients with diabetes (n = 134), which were significantly greater than the respective values of 5.77 +/- 1.89 mmol/l, 15.6 +/- 2.34% and 4.98 +/- 0.80% in those without diabetes (n = 158) (P < 0.0001). BaPWV was 21.69 +/- 6.90 m/s in HD patients with diabetes, which was significantly greater than the value of 18.74 +/- 4.89 m/s in those without diabetes (P < 0.0001). When the analysis was performed in a combined population of those patients with and without diabetes, the mean PG (r = 0.155, P < 0.05) and GA (r = 0.117, P < 0.05), but not HbA1c (r = 0.092, P = 0.125), exhibited significant correlations with baPWV. Multivariate regression analysis, which included age, gender, mean blood pressure, and serum levels of albumin, creatinine and LDL cholesterol, to evaluate the independent association of each marker for glycaemic control with baPWV values in HD patients demonstrated that GA, but not HbA1c or PG, was an independent factor that was significantly associated in a positive manner with baPWV in HD patients.
CONCLUSION: It was suggested that poor glycaemic control, as reflected by increased GA values, might be associated with increased arterial stiffening in HD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248645     DOI: 10.1111/j.1365-2265.2008.03202.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

Review 1.  Subcellular localization of guanylate cyclase.

Authors:  H Kimura; F Murad
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

Review 2.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

Review 3.  Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.

Authors:  Jongha Park; Paungpaga Lertdumrongluk; Miklos Z Molnar; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

4.  Emerging trends in optical sensing of glycemic markers for diabetes monitoring.

Authors:  Rishikesh Pandey; Narahara Chari Dingari; Nicolas Spegazzini; Ramachandra R Dasari; Gary L Horowitz; Ishan Barman
Journal:  Trends Analyt Chem       Date:  2015-01-01       Impact factor: 12.296

Review 5.  Updates on the management of diabetes in dialysis patients.

Authors:  Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-03       Impact factor: 3.455

6.  Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus.

Authors:  Kamyar Kalantar-Zadeh; Stephen F Derose; Susan Nicholas; Deborah Benner; Kumar Sharma; Csaba P Kovesdy
Journal:  J Ren Nutr       Date:  2009-01       Impact factor: 3.655

Review 7.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

8.  Raman spectroscopy provides a powerful diagnostic tool for accurate determination of albumin glycation.

Authors:  Narahara Chari Dingari; Gary L Horowitz; Jeon Woong Kang; Ramachandra R Dasari; Ishan Barman
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

9.  The roles of glycated albumin as intermediate glycation index and pathogenic protein.

Authors:  Kwang Joon Kim; Byung-Wan Lee
Journal:  Diabetes Metab J       Date:  2012-04-17       Impact factor: 5.376

10.  Glycated Albumin is Independently Associated With Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients.

Authors:  Hoon Young Choi; Seung Kyo Park; Gi Young Yun; Ah Ran Choi; Jung Eun Lee; Sung Kyu Ha; Hyeong Cheon Park
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.